SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-101615
Filing Date
2023-09-18
Accepted
2023-09-18 16:31:45
Documents
16
Period of Report
2023-09-18
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2326324d1_8k.htm   iXBRL 8-K 32361
2 EXHIBIT 3.1 tm2326324d1_ex3-1.htm EX-3.1 10078
3 EXHIBIT 4.1 tm2326324d1_ex4-1.htm EX-4.1 12375
7 GRAPHIC tm2326324d1_ex4-1img001.jpg GRAPHIC 387017
8 GRAPHIC tm2326324d1_ex4-1img002.jpg GRAPHIC 207618
  Complete submission text file 0001104659-23-101615.txt   1059648

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA axla-20230918.xsd EX-101.SCH 3030
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE axla-20230918_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axla-20230918_pre.xml EX-101.PRE 22369
10 EXTRACTED XBRL INSTANCE DOCUMENT tm2326324d1_8k_htm.xml XML 3391
Mailing Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE THIRD FLOOR CAMBRIDGE MA 02139 617-868-0949
Axcella Health Inc. (Filer) CIK: 0001633070 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38901 | Film No.: 231261553
SIC: 2836 Biological Products, (No Diagnostic Substances)